OPEN END-TURBO-OPTIONSSCHEIN - NOVAVAX Stock

Certificat

DE000HG4FTE7

Real-time BOERSE MUENCHEN 01:37:08 2024-05-23 pm EDT
5.3 EUR +1.15% Intraday chart for OPEN END-TURBO-OPTIONSSCHEIN - NOVAVAX
Current month-18.00%
1 month-18.51%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-23 5.3 +1.15%
24-05-22 5.24 -1.32%
24-05-21 5.31 -1.12%
24-05-20 5.37 -1.47%
24-05-17 5.45 +1.30%

Real-time BOERSE MUENCHEN

Last update May 23, 2024 at 01:37 pm EDT

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellPUT
Underlying NOVAVAX, INC.
Issuer HSBC
WKN HG4FTE
ISINDE000HG4FTE7
Date issued 2022-07-14
Strike 72.43 $
Maturity Unlimited
Parity 10 : 1
Emission price 0.46
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 6.47
Lowest since issue 0.93

Company Profile

Novavax, Inc. is a biotechnology company, which discovers, develops and commercializes vaccines to prevent serious infectious diseases. The Company offers a differentiated vaccine platform that combines a recombinant protein approach, advanced nanoparticle technology and its patented Matrix-M adjuvant to enhance the immune response. It has one commercial program, for vaccines to prevent COVID-19, which includes Nuvaxovid prototype COVID-19 vaccine (NVX-CoV2373 or prototype vaccine) and Nuvaxovid updated COVID-19 vaccine (NVX-CoV2601 or updated vaccine) (collectively, COVID-19 Vaccine). The Company is advancing the development of other vaccine candidates, including its COVID19-Influenza Combination (CIC) vaccine candidate and additional vaccine candidates. Its COVID-19 Vaccine and its other vaccine candidates incorporate the Company’s proprietary Matrix-M adjuvant to enhance the immune response and stimulate higher levels of functional antibodies and induce a cellular immune response.
Sector
-
More about the company

Ratings for Novavax, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C-
More Ratings

Consensus: Novavax, Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
15.7 USD
Average target price
19.75 USD
Spread / Average Target
+25.80%
Consensus